Drugs.com - Pharma Industry News

Lecanemab for Alzheimer Disease Safe, Feasible in Real-World Practice

THURSDAY, May 15, 2025 -- Treatment of Alzheimer disease with lecanemab is feasible in a specialty memory clinic, and the frequency of significant adverse events is similar to clinical trials, according to a study published online May 12 in JAMA...

May 15, 2025 - 18:32
 0
Lecanemab for Alzheimer Disease Safe, Feasible in Real-World Practice
THURSDAY, May 15, 2025 -- Treatment of Alzheimer disease with lecanemab is feasible in a specialty memory clinic, and the frequency of significant adverse events is similar to clinical trials, according to a study published online May 12 in JAMA...
Read More

Tags:

Previous Article

A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases

Next Article

Some Triple Negative Breast Cancers Might Be Avoided by Longer Breastfeeding

Related Posts

Molecular Monitoring Improves Survival in Some Patients With Newly Diagnosed Leukemia

Molecular Monitoring Improves Survival in Some Patients...

May 14, 2025  0

BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection

BCG Revaccination Does Not Provide Protection From Sust...

May 12, 2025  0

No Link Found Between COVID-19 Vaccination During Pregnancy and Spontaneous Abortion

No Link Found Between COVID-19 Vaccination During Pregn...

May 15, 2025  0